Showing 1601-1610 of 2223 results for "".
- Candela and VBF Team Up with Physicians to Provide Laser Treatments to Families With Vascular Birthmarkshttps://modernaesthetics.com/news/candela-and-vbf-team-up-with-physicians-to-provide-laser-treatments-to-families-with-vascular-birthmarks/2471984/
- ARTAS iX: Real-World Evaluation Study Shows Benefithttps://modernaesthetics.com/news/artas-ix-real-world-evaluation-study-shows-benefit/2472009/Restoration Robotics, Inc. (NASDAQ: HAIR), the global leader in robotic hair restoration, today announced results from a real-world evaluation study of The new ARTAS iX™ Robotic Hair Restoration System demonstrates clinical efficiency in hair harvesting and implan
- Alastin Skincare Introduces TransFORM Body Treatment at ASDS Meetinghttps://modernaesthetics.com/news/alastin-skincare-introduces-transform-body-treatment-at-asds-meeting/2472018/
- New for EBD-Based Acne Care: Sebacia Microparticles Clearedhttps://modernaesthetics.com/news/new-for-ebd-based-acne-care-sebacia-microparticles-cleared/2472033/Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Sebacia, Inc. had submitted its 510(k) submission to the FDA in June 2018. Sebacia Mic
- Back by Popular Demand: Sciton's Bright Lights Big City BBL Tourhttps://modernaesthetics.com/news/back-by-popular-demand/2472107/Sciton. Inc.’s
- Game On: Revance Readies for Launch of their Botox Competitorhttps://modernaesthetics.com/news/game-on-revance-readies-for-launch-of-their-botox-competitor/2472111/With the advent of four new positions, Revance Therapeutics is expanding their commercialization team in anticipation of the product launc
- BTL Geared to Share New Research, Latest Innovation at American Society for Laser Medicine & Surgery Annual Conferencehttps://modernaesthetics.com/news/btl-geared-to-share-new-research-latest-innovation-at-american-society-for-laser-medicine-surgery-annual-conference/2472110/
- Revance, Mylan Partner to Develop Botox Biosimilarhttps://modernaesthetics.com/news/revance-mylan-partner-to-develop-botox-biosimilar/2472123/Mylan N.V. and
- Dr. Kelly Huang to Obalon; Alisa Lask to Oversee Galderma's Aesthetic & Corrective Business Unithttps://modernaesthetics.com/news/dr-kelly-huang-to-obalon-alisa-lask-to-oversee-galdermas-aesthetic-corrective-business-unit/2472202/Former Galderma general manager Kelly Huang, Ph.D. is now Obalon’s Chief Operating Officer. In this new role, Dr. Huang will be responsible for the key commercial functions of sales, marketing, operations, and quality assurance. In related
- Syneron Candela Becomes Private Company with Completion of Transaction with Funds Advised by Apax Partnershttps://modernaesthetics.com/news/syneron-candela-becomes-private-company-with-completion-of-transaction-with-funds-advised-by-apax-partners/2472211/Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400 million. The transacti